Gilead Sciences, Inc.

Gilead Sciences, Inc. - PE Ratioverified

GIS.DE

Price:

$115.7

Market Cap:

$165.39B

Gilead Sciences, Inc. is a biopharmaceutical innovator dedicated to the research, development, and global commercialization of medicines that address significant unmet medical needs across the United States, Europe, and other international regions. Its extensive product lineup includes leading treatments for HIV/AIDS, such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla. For COVID-19, the company provides Veklury, an injectable therapy for intravenous administration. Gilead also offers a robust portfolio of drugs combating various liver diseases, specifically Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, it supplies therapeutic solutio...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2000-01-03

Stock Exchange

XETRA

Ticker

GIS.DE

The PE Ratio as of August 2026 (TTM) for Gilead Sciences, Inc. (GIS.DE) is -93.28

According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -93.28. This represents a change of -904.95% compared to the average of 11.59 of the last 4 quarters.

Gilead Sciences, Inc. (GIS.DE) Historical PE Ratio (quarterly & annually)

How has GIS.DE PE Ratio performed in the past?

The mean historical PE Ratio of Gilead Sciences, Inc. over the last ten years is 96.96. The current -93.28 PE Ratio has changed -9720.27% with respect to the historical average. Over the past ten years (40 quarters), GIS.DE's PE Ratio was at its highest in in the December 2018 quarter at 6.80K. The PE Ratio was at its lowest in in the September 2019 quarter at -17.22.

Quarterly (TTM)
Annual

Average

96.96

Median

17.89

Minimum

7.10

Maximum

595.10

Gilead Sciences, Inc. (GIS.DE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Gilead Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.78%

Maximum Annual PE Ratio = 595.10

Minimum Annual Increase = -97.54%

Minimum Annual PE Ratio = 7.10

Quarterly (TTM)
Annual
YearPE RatioChange
202517.94-92.62%
2024243.081.26%
202317.84-23.93%
202223.4660.23%
202114.64-97.54%
2020595.103.78%
201915.332.90%
201814.89-26.41%
201720.24184.87%
20167.10-13.15%

Gilead Sciences, Inc. (GIS.DE) Average PE Ratio

How has GIS.DE PE Ratio performed in the past?

The current PE Ratio of Gilead Sciences, Inc. (GIS.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

92.96

5-year avg

63.39

10-year avg

96.96

Gilead Sciences, Inc. (GIS.DE) PE Ratio vs. Peers

How is GIS.DE’s PE Ratio compared to its peers?

Gilead Sciences, Inc.’s PE Ratio is less than Pfizer Inc. (35.33), less than Amgen Inc. (25.34), less than Pfizer Inc. (35.33), less than Sanofi (23.03), less than Bristol-Myers Squibb Company (14.26), less than Danaher Corporation (36.24), less than Boston Scientific Corporation (19.88), less than Merck & Co., Inc. (102.04), less than Stryker Corporation (34.84), less than Medtronic Plc (23.24),

Build a custom stock screener for Gilead Sciences, Inc. (GIS.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gilead Sciences, Inc. (GIS.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Gilead Sciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Gilead Sciences, Inc. (GIS.DE)?

What is the highest PE Ratio for Gilead Sciences, Inc. (GIS.DE)?

What is the 3-year average PE Ratio for Gilead Sciences, Inc. (GIS.DE)?

What is the 5-year average PE Ratio for Gilead Sciences, Inc. (GIS.DE)?

How does the current PE Ratio for Gilead Sciences, Inc. (GIS.DE) compare to its historical average?